Pharmacological basis of thrombolytic therapy
Kleking, G.P.; Bokarev, I.N.
Klinicheskaia Meditsina 68(6): 13-19
1990
ISSN/ISBN: 0023-2149 PMID: 2214624 Document Number: 356034
Document emailed within 1 workday
Related Documents
Krieglstein, G.K. 1973: Pharmacological basis of therapy with miotics Klinische Monatsblatter für Augenheilkunde 163(4): 471-476Savchenko, A.P.; Leisch, F.; Pomerantsev, E.V.; Kirschner, K. 1991: Delayed balloon dilatation of the coronary arteries after thrombolytic therapy in acute myocardial infarct: a comparison with thrombolytic therapy Terapevticheskii Arkhiv 63(8): 56-61
Zilletti, L.; Giotti, A.; Mannaioni, P.F.; Masini, E.; Franconi, F. 1982: General pharmacological basis of the therapy for broncho-asthmatic syndromes Panminerva Medica 24(4): 288-289
Kothe, K. 1990: Thrombolytic therapy in acute myocardial infarct. 2. Clinical studies with thrombolytic therapy Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(10): 269-274
Cieslinski, G.; Klepzig, H. 1993: Therapy of acute myocardial infarct with thrombolytic drugs. Can use of thrombolytic therapy be further improved? Fortschritte der Medizin 111(13): 209
Kothe, K. 1990: Thrombolytic therapy in acute myocardial infarct. 1. Markers for evaluating effectiveness and thrombolytic substances Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 45(7): 177-183
Klöking, K.; Vogel, H. 1981: Pharmacological and clinical study of the thrombolytic effectiveness of ocrase Kardiologiia 21(8): 36-38
Hazin, R.; Dixon, J.A.; Bhatti, M.T. 2009: Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Current Opinion in Ophthalmology 20(3): 210-218
Castaigne, A.; Duval-Moulin, A.M.; Dubois-Randé, J.L.; Merlet, P. 1989: Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction Archives des Maladies du Coeur et des Vaisseaux 82(Special Issue 3): 15-20
Hugelin, A. 1982: Pharmacological basis of the action of isaxonine La Nouvelle Presse Medicale 11(16): 1221-1226
Scriabine, A.; Kazda, S. 1989: Pharmacological basis for use of calcium antagonists in hypertension Magnesium 8(5-6): 253-265
Breckenridge, B.M. 1983: Pharmacological basis of therapeutics. Adenosine receptors Journal of the Medical Society of New Jersey 80(11): 947-949
Davidoff, F. 1973: Oral hypoglycemic agents: the pharmacological basis of their clinical use Rhode Island Medical Journal 56(10): 409-414
Wolff, D.J. 1984: Pharmacological basis of therapeutics: eicosanoids--mediators of biological functions Journal of the Medical Society of New Jersey 81(6): 503-505
Minker, E.; Matejka, Z. 1981: Pharmacological basis of dosage form of two antimalarials: chloroquine and mepacrine Acta Physiologica Academiae Scientiarum Hungaricae 57(2): 197-200
Richards, R.J.; Thakur, V.; Reisin, E. 1996: Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment Journal of Human Hypertension 10(Suppl 3): S59-S64
De Gennes, J.L. 1973: Biological exploration and basis of dietetic and pharmacological treatment for atheogenic hyperlipemia Annales de Cardiologie et d'Angeiologie 22(1): 33-40
Kalbhen, D.A. 1978: The biochemical and pharmacological basis of the anti-phlogistic/antirheumatic effect of pentosan polysulfate Wiener Klinische Wochenschrift 90(3): 101-105
Van de Loo, J. 1992: Thrombolytic therapy Der Internist 33(4): 195-196
Quattrini, L.; Tomassini, P.F.; Paciaroni, E. 1994: Ergometric test: prognostic significance in the pre-thrombolytic and thrombolytic period Minerva Cardioangiologica 42(5): 217-221